Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Bio-Techne Corp. (TECH) announced the automation of RNAscope COVID-19 probes on BOND RX, Leica Biosystems's staining platform, which allow researchers the ability to automate their COVID-19 research protocols, reducing manual labor and turnaround time.


RTTNews | Aug 19, 2020 08:52AM EDT

08:52 Wednesday, August 19, 2020 (RTTNews.com) - Bio-Techne Corp. (TECH) announced the automation of RNAscope COVID-19 probes on BOND RX, Leica Biosystems's staining platform, which allow researchers the ability to automate their COVID-19 research protocols, reducing manual labor and turnaround time.

The RNAscope probes are designed to detect SARS-Cov-2 viral RNA, SARS-Cov-2 viral replication sequences, and cellular receptors targeted by the virus.

Kim Kelderman, President, Diagnostics and Genomics Segment, Bio-Techne, said: "We believe RNAscope probes will enable researchers to gain a greater understanding of the pathogenesis of this disease. The availability of these probes on the automated Leica Biosystems platform will expediate important discoveries."

Read the original article on RTTNews ( https://www.rttnews.com/3122511/bio-techne-announces-automation-of-covid-19-research-protocols-on-leica-s-staining-platform.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2020 RTTNews.com All Rights Reserved






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC